companydata.dkcompanydata.dk

NORITNIELSEN ApS PHARMASOURCE: Financial statements 2022

CVR: 33266707

Source: annual report 2022, Danish Business Authority

01/10/2021 – 30/09/2022

NORITNIELSEN ApS PHARMASOURCE (CVR 33266707) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,629,712 and a net result of DKK 1,495,781 compared with DKK 837,450 the year before. That is an increase of 19.9% compared with the year before. Equity in the 2022 report amounted to DKK 2,088,547. The solvency ratio was 70.4%. The company had 2 employees in the financial year.

Gross Profit
DKK 3,629,712
Profit/Loss
DKK 1,495,781
Equity
DKK 2,088,547
Total Assets
DKK 2,966,705
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-3.6M1.5M2.1M2
2021-3M837K2.1M2
2020-2.9M805K2.1M2
2019-3.4M1.1M2.5M2
2018-4M1.5M2.6M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on NORITNIELSEN ApS PHARMASOURCE

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Lisa Norit steps down as director of NORITNIELSEN ApS PHARMASOURCEOct 30, 2022

As of October 30, 2022, Lisa Norit has stepped down as director of NORITNIELSEN ApS PHARMASOURCE.

NORITNIELSEN ApS PHARMASOURCE: The 2021 annual report is outJan 31, 2022

NORITNIELSEN ApS PHARMASOURCE has published its annual report for 2021. Gross profit came to DKK 3,028,019, and the net result was DKK 837,450.

About NORITNIELSEN ApS PHARMASOURCE

NORITNIELSEN ApS PHARMASOURCE was a Danish company of the type Anpartsselskab based in Farum, founded in 2010. The company has been dissolved on 1 May 2025. The company was registered under the industry Virksomhedsrådgivning og andre rådgivningsaktiviteter. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 374,773 and a net result of DKK 22,170 compared with DKK 77,974 the year before. Equity in the 2024 report amounted to DKK 180,144.

Source: annual report 2024, Danish Business Authority